AXSOME THERAPEUTICS
AXSOME THERAPEUTICS
Share · US05464T1043 · AXSM · A2AA7B (LSSI)
Overview Financial Indicators
97,92 EUR
1,07 % 1,03 EUR
Lang & Schwarz (XNAS) · Current prices and charts at MoneyPeak
06.06.2025 19:59

Current Prices from AXSOME THERAPEUTICS

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
AXSM
USD
06.06.2025 19:59
111,84 USD
110,66 USD
+1,07 %
XLON: London
London
0HKF.L
USD
06.06.2025 15:36
110,83 USD
110,66 USD
+0,16 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
-0,45 % 3,73 % 1,42 % -12,72 % 3,47 % 43,46 % 38,17 %

Company Profile for AXSOME THERAPEUTICS Share

Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation. It is also developing AXS-07, a novel, oral, rapidly absorbed, multi-mechanistic, and investigational medicine that has completed two Phase III trials for the acute treatment of migraine; AXS-12, a selective and potent norepinephrine reuptake inhibitor, which is in Phase III trial to treat narcolepsy; and AXS-14, a novel, oral, and investigational medicine that is in Phase III trial for the treatment of fibromyalgia. Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.

Invested Funds

The following funds have invested in: AXSOME THERAPEUTICS invested:

Fund
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in million
33,03
Percentage (%)
0,08 %

Company Data

Name AXSOME THERAPEUTICS
Company Axsome Therapeutics, Inc.
Symbol AXSM
Website https://www.axsome.com
Primary Exchange LSSI Lang & Schwarz
WKN A2AA7B
ISIN US05464T1043
Asset Class Share
Sector Healthcare
Industry Medical - Pharmaceuticals
CEO Dr. Herriot Tabuteau M.D.
Market Capitalization 5 Mrd.
Country United States of America
Currency EUR
Employees 0,7 T
Address 22 Cortlandt Street, 10007 New York
IPO Date 2018-01-29

Ticker Symbols

Name Symbol
Frankfurt 19X.F
London 0HKF.L
NASDAQ AXSM

More Shares

Investors who AXSOME THERAPEUTICS hold also have the following shares in their portfolio:
AMAZON.CO INC
AMAZON.CO INC Share
APPLE INC
APPLE INC Share
BASF SE
BASF SE Share
CHINA COAL ENERGY H  YC 1
CHINA COAL ENERGY H YC 1 Share
H+A EQ.SM.CA.EMU B
H+A EQ.SM.CA.EMU B Fund
HENSOLDT AG
HENSOLDT AG Share
MANNING VENTURES INC
MANNING VENTURES INC Share
MARATHON DIGITAL HOLDINGS INC
MARATHON DIGITAL HOLDINGS INC Share
MICRON TECHNOLOGIESLOGY INC
MICRON TECHNOLOGIESLOGY INC Share
MICROSTRATEGY INC - CLASS A
MICROSTRATEGY INC - CLASS A Share
NU S  CL.A DL-,000066
NU S CL.A DL-,000066 Share
NVIDIA CORP
NVIDIA CORP Share
TESLA INC
TESLA INC Share
Vanguard Intermediate-Term Bond Index Fund Admiral Shares
Vanguard Intermediate-Term Bond Index Fund Admiral Shares ETF
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025